Advocating at the global level to achieve cardiovascular health for everyone
Advocating for fiscal policies, including taxes on tobacco, alcohol and sugar-sweetened beverages, to help fund UHC.
Learn moreAir pollution is a significant risk factor for CVD and as such must urgently be addressed through research, education, and policy change.
Learn moreRHD is a preventable, treatable form of cardiovascular disease that affects over 33 million people around the world, chiefly in low-resource settings.
Learn moreAs smoking prevalence continues to climb in the developing world, we are mobilizing the CVD community in the fight against tobacco.
Learn moreWHF is the only organization representing the CVD community in Official Relations with the WHO, the global authority on public health policy.
Learn moreOur advocacy experts work closely with the UN, its agencies, and other international bodies to influence global policies, strategies and funding.
Learn moreThis Committee is composed of experts representing each WHO Region. It serves to inform and approve science-based policy proposals.
Learn moreThe TEG supports the development of WHF position papers, external statements, and internal policies to advance progress on global tobacco control.
Learn moreThe APEG guides the work of WHF in the area of air pollution and CVD, identifying areas for further research and prioritizing key advocacy objectives.
Learn moreThe Global Coalition for Circulatory Health brings together international, regional and national stakeholders in circulatory health.
Learn moreOn 23 September 2019, world leaders adopted the first United Nations Political Declaration on Universal Health Coverage at the UN General Assembly high-level meeting on Universal Health Coverage (UHC). The document represents a comprehensive set of health commitments, providing a framework for action on UHC. The Declaration set the ambitious goals of progressively covering 1 […]
Universal Health Coverage
We are thrilled to announce that the next edition of the World Heart Summit will take place in Geneva, Switzerland on 19-21 May 2023, ahead of the 76th World Health Assembly. The timing and location of this invitation-only event — which brings together leaders and innovators from around the world to explore the most pressing challenges in global […]
This is a statement made at the seventy-third session of the World Health Organization Regional Committee for the Western Pacific, held from 24 to 28 October 2022 in Manila, Philippines. Honourable Chair, Distinguished Delegates, The endorsement of the draft Regional Framework on the Future of Primary Health Care in the Western Pacific is an important […]
Cardiovascular disease is responsible for an estimated 18.6 million deaths every year and remains the leading cause of mortality worldwide. Raised cholesterol is widely recognized as a major risk factor for heart disease and stroke. According to the Global Burden of Disease Study, approximately 4.4 million deaths were attributable to elevated LDL cholesterol in 2019. […]
Cholesterol
The World Heart Vision 2030: Driving Policy Change delineates a viable future that improves health, spares costs an… https://t.co/v2dv0ZxaOV
about 8 hours ago
RT @GlobalHeartHub: People with diabetes have a twofold increased risk of developing #CVD 📢 We are delighted to share that the findings fr…
about 16 hours ago
#ACC23/#WCCardio is really just around the corner! 🚨 Advance registration ENDS on 1 February. Register today:… https://t.co/IFw5xF7reV
about 16 hours ago
Our heart is missing! ❤️ Can you guess why? Today is Kawasaki Disease Awareness Day! Kawasaki disease is a leadin… https://t.co/I9YVNNBeYe
8:37 - 26 January
RT @MNTsenegal: La Division de Lutte contre les MNT, en partenariat avec la Société Sénégalaise de Cardiologie (SOSECAR) et la World Heart…
4:52 - 25 January